European journal of nuclear medicine and molecular imaging

Keyphrases

Publications

volume 51, number 9, 2024

Luca Sofia, Federico Massa, Stefano Raffa, Matteo Pardini, Dario Arnaldi, Matteo Bauckneht, Silvia Morbelli
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer's disease (AD) mimickers. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Soren Hess, Edel Noriega-Álvarez, Lucia Leccisotti, Giorgio Treglia, Domenico Albano, Anne Roivainen, Andor W J M Glaudemans, Olivier Gheysens
EANM consensus document on the use of [ 18 F]FDG PET/CT in fever and inflammation of unknown origin. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Miriam Pepponi, Valentina Berti, Elsa Fasciglione, Flavio Montanini, Letizia Canu, Fabrice Hubele, Elisabetta Abenavoli, Vittorio Briganti, Elena Rapizzi, Anne Charpiot, David Taieb, Karel Pacak, Bernard Goichot, Alessio Imperiale
[ 68 Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Murray Bruce Reed, Patricia Anna Handschuh, Clemens Schmidt, Matej Murgaš, David Gomola, Christian Milz, Sebastian Klug, Benjamin Eggerstorfer, Lisa Aichinger, Godber Mathis Godbersen, Lukas Nics, Tatjana Traub-Weidinger, Marcus Hacker, Rupert Lanzenberger, Andreas Hahn
Validation of cardiac image-derived input functions for functional PET quantification. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Zhiwei Huang, Junhao Wu, Yihui Guan, Yumei Wei, Fang Xie, Yifeng Shen
PET/CT study of dopamine transporter (DAT) binding with the triple reuptake inhibitor toludesvenlafaxine in rats and humans. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa
Optimizing the pharmacokinetics of an 211 At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Paola Mapelli, Carolina Bezzi, Francesca Muffatti, Samuele Ghezzo, Carla Canevari, Patrizia Magnani, Marco Schiavo Lena, Anna Battistella, Paola Scifo, Valentina Andreasi, Stefano Partelli, Arturo Chiti, Massimo Falconi, Maria Picchio
Preoperative assessment of lymph nodal metastases with [ 68 Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
David Haberl, Clemens P Spielvogel, Zewen Jiang, Fanny Orlhac, David Iommi, Ignasi Carrió, Irène Buvat, Alexander R Haug, Laszlo Papp
Multicenter PET image harmonization using generative adversarial networks. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Hong Song, Maria Isabel Leonio, Valentina Ferri, Heying Duan, Carina Mari Aparici, Guido Davidzon, Benjamin L Franc, Farshad Moradi, Jagruti Shah, Colin P Bergstrom, Alice C Fan, Sumit Shah, Ali Raza Khaki, Sandy Srinivas, Andrei H Iagaru
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [ 177 Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Yuxiang Han, Hui Liu, Yimin Li, Zhibo Liu
B-Glycine as a marker for β cell imaging and β cell mass evaluation. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
David Haberl, Clemens P Spielvogel, Zewen Jiang, Fanny Orlhac, David Iommi, Ignasi Carrió, Irène Buvat, Alexander R Haug, Laszlo Papp
Multicenter PET image harmonization using generative adversarial networks. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Congcong Yu, Lin Chen, Rui Zhou, Hong Zhang
Latent phosphaturic mesenchymal tumor in left planta detected by [ 18 F]F-AlF-NOTA-octreotide PET/CT. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Kilian Kluge, Holger Einspieler, David Haberl, Clemens Spielvogel, Dominik Amereller, Gerda Egger, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Marcus Hacker, Lukas Kenner, Alexander R Haug
Comparison of discovery rates and prognostic utility of [ 68 Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Guangfa Bao, Ziqiang Wang, Luoxia Liu, Buchuan Zhang, Shuang Song, Dongdong Wang, Siyuan Cheng, Eu-Song Moon, Frank Roesch, Jun Zhao, Bo Yu, Xiaohua Zhu
Targeting CXCR4/CXCL12 axis via [ 177 Lu]Lu-DOTAGA.(SA.FAPi) 2 with CXCR4 antagonist in triple-negative breast cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
G B Spoelstra, S N Blok, L Reali Nazario, L Noord, Y Fu, N A Simeth, F F A IJpma, M van Oosten, J M van Dijl, B L Feringa, W Szymanski, P H Elsinga
Synthesis and preclinical evaluation of novel 18 F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Gianpaolo Di Santo, Giulia Santo, Vladan Martinovic, Dominik Wolf, Andreas Pircher, Anna Sviridenko, Judith Löffler-Ragg, Elisabeth von Guggenberg, Irene J Virgolini
Cholecystokinin-2 receptor targeting by [ 68 Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Tiancheng Li, Mimi Xu, Shuye Yang, Guolin Wang, Yinuo Liu, Kaifeng Liu, Kui Zhao, Xinhui Su
Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Min Zhang, Rui Guo, Hanzhong Wang, Jun Zhao, Biao Li
Rapid advancements in PET/MR: the 4th chinese PET/MR academic symposium. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Adeline Zinsz, Celso Pouget, Fabien Rech, Luc Taillandier, Marie Blonski, Samir Amlal, Laetitia Imbert, Timothée Zaragori, Antoine Verger
The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Yaqi Tian, Hongliang Shen, Lingbing Li, Xiaohua Jia, Jin Liu, Zhenhua Hu, Liang Wang, Zhenyu Zhang
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Samantha Delaney, Outi Keinänen, Dennis Lam, Andrew L Wolfe, Takao Hamakubo, Brian M Zeglis
Cadherin-17 as a target for the immunoPET of adenocarcinoma. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Linlin Li, Jiarou Wang, Guochang Wang, Rongxi Wang, Wenbin Jin, Jie Zang, Huimin Sui, Chenhao Jia, Yuanyuan Jiang, Haiyan Hong, Lin Zhu, David Alexoff, Karl Ploessl, Hank F Kung, Zhaohui Zhu
Comparison of novel PSMA-targeting [ 177 Lu]Lu-P17-087 with its albumin binding derivative [ 177 Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa
Optimizing the pharmacokinetics of an 211 At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Antonio Llombart, Aleix Prat, José Manuel Pérez-García, José Mateos, Tomás Pascual, Santiago Escrivà-de-Romani, Agostina Stradella, Manuel Ruiz-Borrego, Begoña Bermejo de Las Heras, Marleen Keyaerts, Patricia Galvan, Fara Brasó-Maristany, Juan José García-Mosquera, Thomas Guiot, María Gion, Miguel Sampayo-Cordero, Serena Di Cosimo, Jhudit Pérez-Escuredo, Manuel Atienza de Frutos, Javier Cortés, Geraldine Gebhart
Clinicopathological and molecular predictors of [ 18 F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Gianpaolo Di Santo, Giulia Santo, Vladan Martinovic, Dominik Wolf, Andreas Pircher, Anna Sviridenko, Judith Löffler-Ragg, Elisabeth von Guggenberg, Irene J Virgolini
Cholecystokinin-2 receptor targeting by [ 68 Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Yue Tan, Jian Li, Tianzhi Zhao, Ming Zhou, Kehuang Liu, Shijun Xiang, Yongxiang Tang, Vivianne Jakobsson, Pengfei Xu, Xiaoyuan Chen, Jingjing Zhang
Clinical translation of a novel FAPI dimer [ 68 Ga]Ga-LNC1013. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, David Groheux, Gary J R Cook, Gary A Ulaner, Heather A Jacene, Isabel T Rubio, Johan A F Koekkoek, Marie-Jeanne T F D Vrancken Peeters, Philip M P Poortmans, Ritse M Mann, Stephanie L Graff, Elizabeth H Dibble, Lioe-Fee De Geus-Oei
Joint EANM-SNMMI guideline on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Soren Hess, Edel Noriega-Álvarez, Lucia Leccisotti, Giorgio Treglia, Domenico Albano, Anne Roivainen, Andor W J M Glaudemans, Olivier Gheysens
EANM consensus document on the use of [ 18 F]FDG PET/CT in fever and inflammation of unknown origin. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Luca Sofia, Federico Massa, Stefano Raffa, Matteo Pardini, Dario Arnaldi, Matteo Bauckneht, Silvia Morbelli
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer's disease (AD) mimickers. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Antonio Llombart, Aleix Prat, José Manuel Pérez-García, José Mateos, Tomás Pascual, Santiago Escrivà-de-Romani, Agostina Stradella, Manuel Ruiz-Borrego, Begoña Bermejo de Las Heras, Marleen Keyaerts, Patricia Galvan, Fara Brasó-Maristany, Juan José García-Mosquera, Thomas Guiot, María Gion, Miguel Sampayo-Cordero, Serena Di Cosimo, Jhudit Pérez-Escuredo, Manuel Atienza de Frutos, Javier Cortés, Geraldine Gebhart
Clinicopathological and molecular predictors of [ 18 F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Samantha Delaney, Outi Keinänen, Dennis Lam, Andrew L Wolfe, Takao Hamakubo, Brian M Zeglis
Cadherin-17 as a target for the immunoPET of adenocarcinoma. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Andreas Wiggers Nielsen, Ib Tønder Hansen, Berit Dalsgaard Nielsen, Søren Geill Kjær, Jesper Blegvad-Nissen, Kate Rewers, Christian Møller Sørensen, Ellen-Margrethe Hauge, Lars Christian Gormsen, Kresten Krarup Keller
The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica-a prospective study of 101 patients. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Andreas Wiggers Nielsen, Ib Tønder Hansen, Berit Dalsgaard Nielsen, Søren Geill Kjær, Jesper Blegvad-Nissen, Kate Rewers, Christian Møller Sørensen, Ellen-Margrethe Hauge, Lars Christian Gormsen, Kresten Krarup Keller
The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica-a prospective study of 101 patients. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Guillaume Hourcau, David Taïeb
Comment on: Is work overload associated with diagnostic errors on [ 18 F]FDG PET/CT. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Chao Li, Rachel J Saladin, Weibo Cai, Weiyu Chen
STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Elif Hindié
The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Sandra Gonzalez, Frédéric Comte, Jean-Marc Israël, Fabrice Rezungles, Pierre Le Coz, David Taïeb
Patient communication of nuclear imaging results: do nuclear medicine practitioners have a role to play? European journal of nuclear medicine and molecular imaging 51 (9) (2024)
David Groheux, Sofia C Vaz, Gary A Ulaner, Gary J R Cook, John Patrick Pilkington Woll, Ritse M Mann, Philip Poortmans, Fatima Cardoso, Heather Jacene, Stephanie L Graff, Isabel T Rubio, Marie-Jeanne Vrancken Peeters, Elizabeth H Dibble, Lioe-Fee de Geus-Oei
Joint EANM-SNMMI guidelines on the role of 2-[ 18 F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Kilian Kluge, Holger Einspieler, David Haberl, Clemens Spielvogel, Dominik Amereller, Gerda Egger, Gero Kramer, Bernhard Grubmüller, Shahrokh Shariat, Marcus Hacker, Lukas Kenner, Alexander R Haug
Comparison of discovery rates and prognostic utility of [ 68 Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Haodong Hou, Yuan Pan, Yanzhi Wang, Yuze Ma, Xiaobing Niu, Suan Sun, Guihua Hou, Weijing Tao, Feng Gao
Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa
Optimizing the pharmacokinetics of an 211 At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Rajiv Ranjit Nair, Aprameya Prasad, Omkar Bhatavdekar, Aira Sarkar, Kathleen L Gabrielson, Stavroula Sofou
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
G B Spoelstra, S N Blok, L Reali Nazario, L Noord, Y Fu, N A Simeth, F F A IJpma, M van Oosten, J M van Dijl, B L Feringa, W Szymanski, P H Elsinga
Synthesis and preclinical evaluation of novel 18 F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Guangfa Bao, Ziqiang Wang, Luoxia Liu, Buchuan Zhang, Shuang Song, Dongdong Wang, Siyuan Cheng, Eu-Song Moon, Frank Roesch, Jun Zhao, Bo Yu, Xiaohua Zhu
Targeting CXCR4/CXCL12 axis via [ 177 Lu]Lu-DOTAGA.(SA.FAPi) 2 with CXCR4 antagonist in triple-negative breast cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Antonio Llombart, Aleix Prat, José Manuel Pérez-García, José Mateos, Tomás Pascual, Santiago Escrivà-de-Romani, Agostina Stradella, Manuel Ruiz-Borrego, Begoña Bermejo de Las Heras, Marleen Keyaerts, Patricia Galvan, Fara Brasó-Maristany, Juan José García-Mosquera, Thomas Guiot, María Gion, Miguel Sampayo-Cordero, Serena Di Cosimo, Jhudit Pérez-Escuredo, Manuel Atienza de Frutos, Javier Cortés, Geraldine Gebhart
Clinicopathological and molecular predictors of [ 18 F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Murray Bruce Reed, Patricia Anna Handschuh, Clemens Schmidt, Matej Murgaš, David Gomola, Christian Milz, Sebastian Klug, Benjamin Eggerstorfer, Lisa Aichinger, Godber Mathis Godbersen, Lukas Nics, Tatjana Traub-Weidinger, Marcus Hacker, Rupert Lanzenberger, Andreas Hahn
Validation of cardiac image-derived input functions for functional PET quantification. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Guangfa Bao, Ziqiang Wang, Luoxia Liu, Buchuan Zhang, Shuang Song, Dongdong Wang, Siyuan Cheng, Eu-Song Moon, Frank Roesch, Jun Zhao, Bo Yu, Xiaohua Zhu
Targeting CXCR4/CXCL12 axis via [ 177 Lu]Lu-DOTAGA.(SA.FAPi) 2 with CXCR4 antagonist in triple-negative breast cancer. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Andreas Wiggers Nielsen, Ib Tønder Hansen, Berit Dalsgaard Nielsen, Søren Geill Kjær, Jesper Blegvad-Nissen, Kate Rewers, Christian Møller Sørensen, Ellen-Margrethe Hauge, Lars Christian Gormsen, Kresten Krarup Keller
The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica-a prospective study of 101 patients. European journal of nuclear medicine and molecular imaging 51 (9) (2024)
Luca Sofia, Federico Massa, Stefano Raffa, Matteo Pardini, Dario Arnaldi, Matteo Bauckneht, Silvia Morbelli
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer's disease (AD) mimickers. European journal of nuclear medicine and molecular imaging 51 (9) (2024)